Introducing FLOWTY™ - The Next-Generation Coronary Drug-Coated Balloon
We are thrilled to announce FLOWTY™ Paclitaxel-Coated Balloon Catheter - Barty Medical's innovative coronary DCB, now MDR-approved for the treatment of in-stent restenosis (ISR).
Why FLOWTY™ stands out in coronary intervention:
✨ Excipient-Free Coating - A Game-Changer in Safety
Unlike conventional DCBs that use iopromide-based excipients (associated with 0.6–0.8% allergic reaction risk), FLOWTY™ delivers paclitaxel without any excipient. Preclinical studies confirm significantly reduced inflammatory response and thrombus formation compared to existing products.
💗 Nanoscale Acicular Paclitaxel Technology
With particle diameters ≤300nm, our proprietary nanoneedle crystals:
• Rapidly penetrate the intima and transfer to the vessel wall
• Form micro-reservoirs for sustained drug release
• Maintain therapeutic concentrations for up to 28 days - with detectable levels beyond 60 days
• Minimize the risk of distal micro-embolization
💯 Exceptional Coating Durability
Rigorous in vitro testing (scratch, bending, expansion, saline immersion) demonstrates FLOWTY™'s superior coating firmness - ensuring maximum drug delivery to the target lesion and greater procedural flexibility.
🫀 Clinically Proven Non-Inferiority
Our randomized, multicenter trial (n=211) was published in Catheter Cardiovasc Interv. 2021 confirmed:
• Non-inferiority vs. SeQuent® Please at 9-month late lumen loss
• Comparable 12-month cardiovascular composite endpoints
• Excellent safety and efficacy profile
At Barty Medical, we're advancing coronary care with innovation that puts patient safety first. FLOWTY™ represents our commitment to delivering effective, safe, and user-friendly interventional solutions.
Hot Tags: flowty™ — the next-generation coronary drug-coated balloon, China, suppliers, manufacturers, factory, customized, OEM
